The Incidence of Central Serous Chorioretinopathy in Olmsted County, Minnesota, 1980–2002

Kitzmann, Anna S.; Pulido, José S.; Diehl, Nancy N.; Hodge, David O.; Burke, J. P.

doi:10.1016/j.ophtha.2007.02.032

Cited by 351 publications

(285 citation statements)

References 16 publications

Supporting

Mentioning

245

Contrasting

Unclassified

Order By: Relevance

“…29 Even though the prevalence of CSC had not been addressed in the Japanese or Asian population and may be higher than that in the Caucasian population, the prevalence of a history of CSC in patients with PCV reported in the present study or by others 14,15 was remarkably high compared with that in the general population.…”

Section: Discussioncontrasting

confidence: 62%

Polypoidal choroidal vasculopathy and history of central serous chorioretinopathy

Toyama

Ohtomo

Noda

et al. 2014

Eye

View full text Add to dashboard Cite

Purpose To evaluate the possible causative role of central serous chorioretinopathy (CSC) in the development of exudative age-related macular degeneration (AMD). Methods In a cross-sectional study at an institutional setting, 150 control subjects who had senile cataract or nasolacrimal duct stenosis and who were older than 50 years were enrolled. The background data for 89 patients with typical AMD (tAMD) and 138 patients with polypoidal choroidal vasculopathy (PCV) were used for comparison. Their medical records were taken for history of CSC, hypertension, systemic steroid use, and smoking. The fundus was also evaluated for signs of atrophic retinal pigment epithelial (RPE) tract and for focal photocoagulation scars in the macula. Results After adjusting for age, gender, and history of hypertension, systemic steroid use, and smoking, history of CSC was significantly more frequent (Po0.0001) in patients with PCV (15 patients, 10.9%) compared with patients with tAMD (2 patients, 2.2%) or control subjects (0 patients). On fundoscopy, an atrophic RPE tract (seven patients) or a focal photocoagulation scar (one patient) was observed only in patients with PCV (eight patients, 5.8%), and the frequency was statistically significant compared with that with tAMD (P ¼ 0.0143) or control subjects (P ¼ 0.0143). The laterality of CSC and AMD involved the same eye in 9 of 10 patients among those who had unilateral AMD and a reported unilateral CSC history. Conclusion A history of CSC may be a predisposing factor for the development of PCV in the Japanese population.

show abstract

Section: Discussioncontrasting

confidence: 62%

Polypoidal choroidal vasculopathy and history of central serous chorioretinopathy

Toyama

Ohtomo

Noda

et al. 2014

Eye

View full text Add to dashboard Cite

show abstract

“…A hyperopic shift due to the anterior displacement of the retina can occur, resulting in blurring of images. Bilateral disease occurs in 5-10% of cases (1).…”

Section: Clinical Featuresmentioning

confidence: 99%

“…Bilateral disease occurs in approximately 20% of patients with idiopathic CSR (1). This risk appears to be higher in steroidtreated patients.…”

Section: Associated Conditionsmentioning

confidence: 99%

Central serous retinopathy

Tarabishy

Ahn

Mandell

et al. 2011

Arthritis Care & Research

View full text Add to dashboard Cite

“…The disease in acute phase, is characterized by neurosensory detachment with subretinal fluid that spontaneously resolved with no treatment. But if it becomes chronic (CSCR), it can result in permanent vision loss with extensive RPE atrophy [1][2][3][4].…”

Section: Introductionmentioning

confidence: 99%

IQ 532 Micropulse green laser treatment for refractory chronic central serous retinopathy

Mamoori¹

2017

Eye Care Vis

View full text Add to dashboard Cite

The Incidence of Central Serous Chorioretinopathy in Olmsted County, Minnesota, 1980–2002

Cited by 351 publications

References 16 publications

Polypoidal choroidal vasculopathy and history of central serous chorioretinopathy

Polypoidal choroidal vasculopathy and history of central serous chorioretinopathy

Central serous retinopathy

IQ 532 Micropulse green laser treatment for refractory chronic central serous retinopathy

Contact Info

Product

Resources

About